Neuroscience News and Research

RSS

New treatment may bring hope for people suffering from muscle cramps

A new treatment may bring hope for people who suffer from muscle cramps or spasms from neuromuscular disorders, diseases such as multiple sclerosis or simply from nighttime leg cramps that keep people from sleeping, according to a study released today that will be presented at the American Academy of Neurology's 67th Annual Meeting in Washington, DC, April 18 to 25, 2015.

19 Feb 2015

Fetal exposure to drugs can cause neurological problems

Research suggests that fetal exposure to chemicals or drugs can cause neurological problems. Babies whose mothers take the epilepsy drug valporic acid (VPA) during pregnancy, for example, appear to have an elevated risk of developing an autism spectrum disorder.

18 Feb 2015

Vanderbilt scientists shed new light on how the brain executes 'mental time travel'

In Proust's novel Recollection of Things Past, the distinctive smell of a lemon madeleine launches the narrator on a long, involved reminiscence of his past that fills seven chapters.

18 Feb 2015

Medics highlight underrepresentation of women in field

Hosted by the Sheffield Women in Medicine Network (SWiM), ‘Building Your Future - SWiM dives in with the Entrepreneurs’, will be a unique opportunity for women to hear personal stories from a diverse group of successful entrepreneurs and share experiences.

17 Feb 2015

Cabazitaxel therapy may be more effective in treating prostate cancer

Prostate cancer is the second leading cause of cancer for men in the United States. Only one class of chemotherapy called taxanes is effective against the disease.

17 Feb 2015

Astrazeneca adopts Labguru software for global management of biological research reagents

BioData, producer of Labguru, the web-based research and lab management system, today announced that the Innovative Medicines unit of global pharmaceutical business, AstraZeneca, has adopted the Labguru platform for the global management of biological reagents used in pre-clinical research.

17 Feb 2015

BGRF announces publication of research into personalising nootropic drugs using in silico prediction methods

The Biogerontology Research Foundation (BGRF), a UK-based charity committed to the support of aging research to address the challenges of a rapidly aging population and to reduce the impact of disease on future generations, announces the publication of research into personalising nootropic drugs using in silico prediction methods.

17 Feb 2015

$Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC$

Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC

Eisai Inc. announced today that the U.S. Food and Drug Administration approved the company's receptor tyrosine kinase inhibitor LENVIMA (lenvatinib) for the treatment of locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer (RAI-R DTC).

13 Feb 2015

Declarative memory helps individuals with neurodevelopmental disorders compensate for dysfunction

Individuals with five neurodevelopmental disorders -- autism spectrum disorder, obsessive-compulsive disorder, Tourette syndrome, dyslexia, and Specific Language Impairment -- appear to compensate for dysfunction by relying on a single powerful and nimble system in the brain known as declarative memory.

13 Feb 2015

Background noise in the brain shapes neuron growth

A process previously thought to be mere background noise in the brain has been found to shape the growth of neurons as the brain develops, according to research from the MRC Centre for Developmental Neurobiology (MRC CDN), Institute of Psychiatry, Psychology & Neuroscience (IoPPN), published in Cell Reports.

13 Feb 2015

Thync electrical neurosignaling reduces brain's response to stress, shows study

Thync today announced results from a study published via bioRxiv that show electrical neurosignaling delivered by its consumer wearable device reduces the brain's response to stress in a chemical-free manner.

13 Feb 2015

Stem cell transplants more effective than mitoxantrone drug for people with severe multiple sclerosis

Stem cell transplants may be more effective than the drug mitoxantrone for people with severe cases of multiple sclerosis (MS), according to a new study published in the February 11, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.

12 Feb 2015

Understanding the pattern of cellular changes that lead to retinal ganglion cell death in glaucoma

Glaucoma, the second leading cause of blindness, usually stems from elevated eye pressure, which in turn damages and destroys specialized neurons in the eye known as retinal ganglion cells. To better understand these cellular changes and how they influence the progression and severity of glaucoma, researchers at University of California, San Diego School of Medicine and Shiley Eye Institute turned to a mouse model of the disease.

12 Feb 2015

Researchers create new intraoperative probe for detecting cancer cells

Brain cancer patients may live longer thanks to a new cancer-detection method developed by researchers at the Montreal Neurological Institute and Hospital - The Neuro, at McGill University and the MUHC, and Polytechnique Montréal.

12 Feb 2015

UH professor wins Friedrich Wilhelm Bessel Research Award

University of Houston developmental psychology professor Arturo Hernandez is among this year's recipients of the Friedrich Wilhelm Bessel Research Award. The award honors his work in mapping how the brain processes language. This research has implication on how language - including a second language - is taught and learned.

12 Feb 2015

Retigabine drug shows promise in protecting the brain against effects of ischemic stroke

Retigabine, a drug approved to treat epilepsy, protected the brain against the effects of ischemic stroke in a study conducted at The University of Texas Health Science Center at San Antonio.

12 Feb 2015

Researchers develop novel approach to identify potential antimalarial drugs

Each year nearly 600,000 people--mostly children under age five and pregnant women in sub-Saharan Africa--die from malaria, caused by single-celled parasites that grow inside red blood cells. The most deadly malarial species--Plasmodium falciparum--has proven notoriously resistant to treatment efforts.

12 Feb 2015

IU School of Medicine launches Industry Collaboration Portal

The Indiana University School of Medicine has launched an initiative and accompanying web site to encourage more collaboration between private industry and researchers at the medical school.

11 Feb 2015

Jefferson, RMA of Philadelphia announce clinical partnership

Jefferson announced today its clinical partnership with RMA of Philadelphia, merging the expertise of two outstanding groups of reproductive specialists on its Center City campus.

11 Feb 2015

UM one step closer to developing potential drug for treating brain cancer

Promentis Pharmaceuticals, Inc. recently announced it will enter an exclusive agreement with UM to commercialize a discovery made by a team of UM faculty scientists that has the potential to treat brain cancer and possibly other disorders of the central nervous system.

11 Feb 2015

Neuroscience News and Research

New treatment may bring hope for people suffering from muscle cramps

Fetal exposure to drugs can cause neurological problems

Vanderbilt scientists shed new light on how the brain executes 'mental time travel'

Medics highlight underrepresentation of women in field

Cabazitaxel therapy may be more effective in treating prostate cancer

Astrazeneca adopts Labguru software for global management of biological research reagents

BGRF announces publication of research into personalising nootropic drugs using in silico prediction methods

Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC

Declarative memory helps individuals with neurodevelopmental disorders compensate for dysfunction

Background noise in the brain shapes neuron growth

Thync electrical neurosignaling reduces brain's response to stress, shows study

Stem cell transplants more effective than mitoxantrone drug for people with severe multiple sclerosis

Understanding the pattern of cellular changes that lead to retinal ganglion cell death in glaucoma

Researchers create new intraoperative probe for detecting cancer cells

UH professor wins Friedrich Wilhelm Bessel Research Award

Retigabine drug shows promise in protecting the brain against effects of ischemic stroke

Researchers develop novel approach to identify potential antimalarial drugs

IU School of Medicine launches Industry Collaboration Portal

Jefferson, RMA of Philadelphia announce clinical partnership

UM one step closer to developing potential drug for treating brain cancer

Event guide: 2nd Neuroscience Innovation Partnering & Licensing Summit eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News